High-quality, cost-effective and rapid-turnaround, GLP testing against hERG

By Steve Jenkinson, VP Drug Discovery and Safety Assessment, Metrion Biosciences

Metrion Biosciences provides GLP hERG testing services which crucial for drug discovery and the Investigational New Drug (IND) process. Our focus is on delivering reliable, regulatory-compliant data quickly and cost-effectively.

Our investment in advanced electrophysiology platforms and highly trained scientists ensures data is robust, reproducible, and meets regulatory standards worldwide. A particular strength is rapid turnaround time, supporting the fast-paced drug discovery process without compromising quality.

Competitive pricing makes GLP hERG testing accessible to companies of all sizes, particularly benefiting smaller biotech firms and academic institutions, without compromising on quality.

Read more about our high-quality, cost-effective and rapid-turnaround, GLP testing against hERG.

Metrion Biosciences

Let’s work together

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.
Contact us for a quote or discussion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram